Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT02834013 |
Title | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase 0 |
Variant Requirements | No |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |